SEC Form D private-offering filing

Tolerance Bio Inc.

Name: Tolerance Bio Inc. - new SEC Form D private-offering filing, Philadelphia, PA
Published: 2026-06-18

A new SEC Form D private-offering notice from Philadelphia, PA, an undisclosed offering target in Biotech. The source filing is one click away.

Tolerance Bio Inc. site↗ Verified via SEC Form D

Biopharmaceutical company developing thymus based cell therapies aimed at restoring immune tolerance for autoimmune disease, transplant rejection and cancer, based in Philadelphia, Pennsylvania.

Filed 2026-06-18Filed to raise UndisclosedFirst money in 2026-06-03Raised so far $15,101,584HQ (as filed) Philadelphia, PASector Biotech ✓Stage (inferred) EarlyCall status Call-ready

Source linked the Form D on EDGAR↗Website verified tolerancebio.com↗Named in the filing 6 executives & directors

Open this row on the live feed →More new filings in Pennsylvania →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.